The relative influence of atomization and evaporation on metered dose inhaler drug delivery efficiency

Aerosol Science and Technology

Volumn 40, Issue 5, 2006, Pages 335-347

  Stein, Stephen W ^a   Myrdal, Paul B ^b  

^a 3M COMPANY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBIENT TEMPERATURES; ATOMIZED DROPLETS; COSOLVENTS; ETHANOL CONCENTRATIONS; ETHANOL DROPLET; METERED-DOSE INHALERS; SIZE RANGES; TURBULENT DEPOSITION;

ATOMIZATION; DRUG DELIVERY; DRUG DOSAGE; ETHANOL; EVAPORATION; HYDROSTATIC PRESSURE; JETS; VAPORS;

DROP FORMATION;

EID: 34548567783     PISSN: 02786826     EISSN: 15217388     Source Type: Journal    
DOI: 10.1080/02786820600612268     Document Type: Article

References (48)

1. Brambilla, G., Ganderton, D., Garzia, R., Lewis, D., Meakin, B., and Ventura, P. (1999). Modulation of Aerosol Clouds Produced by Pressurized Inhalation Aerosols, Int. J. Pharm. 186:3-12.
2. Cicerone, R. J., Stolarski, R. S., and Walters, S. (1974). Stratospheric Ozone Destruction by Man-Made Chlorofluoromethanes, Science 185:1165-1167.
3. Clark, A. (1991). Metered Atomization for Respiratory Drug Delivery. Ph.D. thesis, Loughborough University, Loughborough, UK.
4. Dalby, R. N., and Byron, P. R. (1988). Comparison of Output Particle Size Distributions from Pressurized Aerosols Formulated as Solutions or Suspensions, Pharm. Res. 5(1):36-39.
5. Davies, C. N. (1978). Evaporation of Airborne Droplets. In Fundamentals of Aerosol Science, D. T. Shaw ed., Wiley, New York.
6. Dolovich, M. (1993). Lung Dose, Distribution, and Clinical Response to Therapeutic Aerosols, Aerosol Sci. Technol. 19:230-240.
7. Dunbar, C. A., Watkins, A. P., and Miller, J. F. (1997a). Theoretical Investigation of the Spray from a Pressurized Metered-Dose Inhaler, Atomization and Sprays 7:417-436.
8. Dunbar, C. A.,Watkins, A. P., and Miller, J. F. (1997b). An experimental Investigation of the Spray Issued from a pMDI Using Laser Diagnostic Techniques, J. Aerosol Med. 10:351-368.
9. Finlay,W. H. (2001). The Mechanics of Inhaled Pharmaceutical Aerosols. Academic Press, London.
10. Gabrio, B. J., Stein, S. W., and Velasquez, D. J. (1999). A New Method to Evaluate Plume Characteristics of HFA and CFC Metered Dose Inhalers, Int. J. Pharm. 186:3-12.
11. Gupta, A., Stein, S.W., and Myrdal, P. B. (2003). Balancing Ethanol Cosolvent Concentration with Product Performance in 134a Based Pressurized Metered Dose Inhalers, J. Aerosol Medicine 16 (2):167-174.
12. Harnor, K. J., Perkins, A. C.,Wastie, M.,Wilson, C. G., Sims, E. E., Feely, L. C., and Farr, S. J. (1993). Effect of Vapour Pressure on the Deposition Pattern from Solution Phase Metered Dose Inhalers, Int. J. Pharm. 95:111-116.
13. Harrison, L., Leach, C., Machacek, J., Vanden Burgt, J., and Vogel, J. (1997). Beneficial Effects with Reduced Particle Size and CFC-free Extrafine Aerosol Steroid on Lung Deposition, Absorption, Efficacy and Safety, Am. J. Respir. Crit. Care Med. 155:A666.
14. Hickey, A. J., Martonen, T. B., and Yang, Y. (1996). Theoretical Relationship of Lung Deposition to the Fine Particle Fraction of Inhalation Aerosols, Pharmaceut. Acta Helvet. 71:185-190.
15. Hinds, W.C. (1999). Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles. John Wiley and Sons, New York.
16. Hirst, P. H., Pitcairn, G. R.,Weers, J. G., Tarara, T. E., Clark, A. R., Dellamaary, L. A., Hall, G., Shorr, J., and Newman, S. P. (2002). In Vivo Lung Deposition of Hollow Porous Particles from a Pressurized Metered Dose Inhaler, Pharmaceutical Research 19(3):258-264.
17. Howarth, P. H. (2001). Why Particle Size Should Affect Clinical Response to Inhaled Therapy, J. Aerosol Med. 14:S27-S34.
18. Kapitza, C., Heise, T., McGovern, M., Cefali, E., Buchwald, A., Heinemann, L., Hompesch, M. (2003). Time-Action Profile of a New Pulmonary Insulin Applied with a Metered Dose Inhaler, American Diabetes Association, 63rd Scientific Session, June 13-17, 2003, New Orleans, La.
19. Leach, C. L., Davidson, P. J., and Boudreau, R. J. (1998). Improved Airway Targeting with the CFC-Free HFA-Beclomethasone Metered-Dose Inhaler Compared with CFC-Beclomethasone, Eur. Respir. J. 12:1346-1353.
20. Leach, C. (1999). Effect of Formulation Parameters on Hydrofluoroalkane-Beclomethasone Dipropionate Drug Deposition in Humans, J. Allergy Clin. Immunol. 104:S250-S252.
21. Leach, C. L., Hameister, W. H., and Tomai, M. A. (2000). Oligolactic Acid (OLA) Biomatracies for Sustained Release of Asthma Therapeutics in Respiratory Drug Delivery VII, P. R. Byron, R. N. Dalby, S. J. Farr, and J. Peart, eds., Serentec Press, Raleigh, NC, 75-81.
22. Leach, C.L., Davidson, P.J., Hasselquist, B.E., Boudreau, R. J. (2002). Lung Deposition of Hydrofluoroalkane-134a Beclomethasone is Greater than that of Chlorofluorocarbon Fluticasone and Chlorofluorocarbon Beclomethasone: a Cross-over Study in Healthy Volunteers, Chest. 122:510-516.
23. Lewis, D., Ganderton, D., Meakin, B., and Brambilla, G. (2004). Theory and Practice with Solution Systems in Respirator Drug Delivery IX, R. R. Dalby, P. R. Byron, J. Peart, J. Suman, and S. J. Farr, eds., Davis Healthcare Int'l. Publ., River Grove, IL, pp. 109-115.
24. Lippman, M., and Albert, R. E. (1969). The Effect of Particle Size on the Regional Deposition of Inhaled Aerosols in the Human Respiratory Tract, Am. Ind. Hyg. Ass. J. 30:257-275.
25. Liu, B. Y. H., and Agarwal, J. K. (1974). Experimental Observation of Aerosol Deposition in Turbulent Flow, J. Aerosol Sci. 5:145-155.
26. Marple V. A., and Willeke, K. (1976). Impactor Design, Atmos. Environ. 10:891-896
27. McKenzie, L., and Oliver, M. J. (2000). Evaluation of the Particle Formation Process After Actuation of Solution MDIs, J. Aerosol Med. 13:59.
28. Mitchell, J. P., and Nagel, M. W. (2003). Cascade Impactors for the Size Characterization of Aerosols from Medical Inhalers: Their Uses and Limitations, J. Aerosol Med. 16:341-377.
29. Molina, M. J., and Rowland, F. S. (1974). Stratospheric Sink for Chlor-fluoromethanes: Chlorine Atom-Catalyzed Destruction of Ozone, Nature 249:810-812.
30. Morrow, P. H. (1966). Deposition and Retention Models for Internasal Dosimetry of the Human Respiratory Tract, Health Phys. 12:173-207.
31. Naini,V., Chaudhry, S., Berry, J., Sharpe, S., Hart, J., and Sequeira, J. (2004). Entry Port Selection for Detecting Particle Size Differences in Metered Dose Inhaler Formulations Using Cascade Impaction, Drug Deliv. Industrial Pharm. 30(1):75-82.
32. Newman, S. P., Moren, F., Pavia, D., Corrado, O., and Clarke, S.W. (1982). The Effects of Changes in Metered Volume and Propellant Vapor Pressure on the Deposition of Pressurized Inhalation Aerosols, Int. J. Pharm. 11:337-344.
33. Rance R.W. (1972). Particle Size Distribution Measurement of Hair Spray Using an Image Splitting Particle Size Analyzer, J. Cos. Chem. 23:197-208.
34. Rance, R.W. (1974). Studies of the Factors Controlling the Action of Hairsprays. III: The Influence of ParticleVelocity and Diameter on the Capture of Particles by Arrays of Hair Fibres, J. Cos. Chem. 25:545-561.
35. Ross, D. L., and Gabrio, B. J. (1999). Advances in Metered Dose Inhaler Technology with the Development of a Chlorofluorocarbon-Free Drug Delivery System. J. Aerosol Med. 12:151-160.
36. Smyth H. D. C., Mejia-Millan, E. A., and Hickey, A. J. (2002). The Effect of Ethanol on Solvancy, Vapor Pressure, and Emitted Droplet Size of Solution Metered Dose Inhalers Containing HFA-134a. In Respiratory Drug Delivery VII, R. R. Dalby, P. R. Byron, J. Peart, and S. J. Farr, eds., Davis Horwood Int. Pub., Raleigh NC, pp. 735-738.
37. Stefely, J. S., Duan, D. C., Myrdal, P. B., Ross, D. L., Schultz, D.W., and Leach, C. L. (2000). Design and Utility of aNovel Class of Biocompatible Excipients for HFA-based MDIs. In Respiratory Drug Delivery VII, P. R. Byron, R. N. Dalby, S. J. Farr, and J. Peart, eds., Serentec Press, Raleigh, NC, pp. 83-90.
38. Stefely, J. S. (2002). Novel Excipients for Inhalation Drug Delivery: Expanding the Capabilities of the MDI, Drug Deliv. Tech. 2:62, 64-69.
39. Stein, S.W., and Gabrio, B. J. (2000). Understanding Throat Deposition During Cascade Impactor Testing. In Respiratory Drug Delivery VII, P. R. Byron, R. N. Dalby, S. J. Farr, and J. Peart, eds., Serentec Press, Raleigh, NC. Vol 2, pp. 287-290.
40. Stein, S. W., and Olson, B. A. (1997). Variability in Size Distribution Measurements Obtained Using Multiple Andersen Mark II Cascade Impactors, Pharmaceutical Research, 14:1718-1725.
41. Stein, S. W., and Stefely, J. S. (2003). Reinventing Metered Dose Inhalers: From Poorly Efficient CFC MDIs to Highly Efficient HFA MDIs, Drug Del. Technol. 3(1):46-51.
42. Stein, S., and Myrdal, P. (2004). A Theoretical and Experimental Analysis of Formulation and Device Parameters Affecting Solution MDI Size Distributions, J. Pharm. Sci. 93:2158-2175.
43. Stein, S., Gabrio, B., and Myrdal, P. (2005). The Influence of Vapor Pressure on the Size of Atomized MDI Droplets. In Respiratory Drug Delivery Europe, R. N. Dalby, P. R. Byron, J. Peart, and J. D. Suman, eds., Davis Healthcare Intl. Publishing, River Grove, IL, 151-155.
44. U.S. Pharmacopeia (2005). Physical Tests and Determinations 〈601〉 Aerosols, Nasal Sprays, Metered Dose Inhalers, and Dry Powder Inhalers. The United States Pharmacopial Convention, Inc. Rockville, MD. USP 28, pp. 2359-2377.
45. U.S. Pharmacopeia. (2003). The Official Compendia of Standards, USP 26/NF 21; United States Pharmacopeial Convention, Inc: Rockville, MD. Official Monographs, 56-57.
46. Versteeg, H. K., Hargrave, G., Harrington, L., Shrubb I., and Hodson D. (2000). The Use of Computational Fluid Dynamics (CFD) to Predict pMDI Air Flows and Aerosol Plume Formation. In Respiratory Drug Delivery VII, P. R. Byron, R. N. Dalby, S. J. Farr, and J. Peart, eds., Serentec Press, Raleigh, NC. Vol. 1, pp. 257-264.
47. Wilson, D. M., Peart, J., Martin, B. R., Bridgen, D.T., Byron, P. R., and Lichtman, A. H. (2002). Physicochemical and Pharmacological Characterization of a Δ9-THC Aerosol Generated in a Metered Dose Inhaler, Drug and Alcohol Dependence 67:259-267.
48. Wofsy, S. C., McElroy, M. B., and Sze, N. D . (1975). Freon Consumption: Implications for Atmospheric Ozone, Science 187:535-537.